Launch of a new screening algorithm for glaucoma

The Danish eye-screening software manufacturer, RetinaLyze System A/S (Ltd.), a market leader in retinal screening software, is introducing another new and accessible eye-screening service; an artificial intelligence-based screening service to detect glaucoma called RetinaLyze Glaucoma.

During the launch period, we will be releasing articles and launching screening events to increase awareness about glaucoma.


Automated glaucoma screening using fundus images

RetinaLyze System aims to make eye-screenings accessible for the general public. To make this happen, RetinaLyze System’s services lower the cost of each screening and reduce the price and complexity of the equipment necessary to perform eye-screenings. The new RetinaLyze Glaucoma algorithm furthermore makes it possible for eye-specialists, such as ophthalmologists, optometrists and nurses, to perform glaucoma screenings. RetinaLyze Glaucoma analyzes retinal images automatically. It can assess the risk of having glaucoma and gives a result instantly. The entire process involves only the image from fundus cameras – no visual field analyzer or tonometer is necessary. RetinaLyze Glaucoma is a new feature, which is a part of the RetinaLyze web application. The RetinaLyze web application offers easy-to-use automated analysis of retinal images for early signs of possible Diabetic Retinopathy, AMD and Glaucoma as well as a built-in telemedicine solution.

The ease-of-use, as well as the simplicity of the eye exam and the speed of the result, makes the RetinaLyze service an ideal eye-screening tool for clinics and optometry practices of all sizes.


Read more about us at

Organized by

RetinaLyze System A/S

Contact: Ganesh Ram
Contact Email:

Category: Public educational


12/03/2018 - 30/04/2018
All Day
Map Unavailable

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.